These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9974155)

  • 1. Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase in rat brain.
    Zhang K; Farooqui SM; O'Donnell JM
    Brain Res Dev Brain Res; 1999 Jan; 112(1):11-9. PubMed ID: 9974155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain.
    Ye Y; Conti M; Houslay MD; Farooqui SM; Chen M; O'Donnell JM
    J Neurochem; 1997 Dec; 69(6):2397-404. PubMed ID: 9375671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex.
    Ye Y; O'Donnell JM
    J Neurochem; 1996 May; 66(5):1894-902. PubMed ID: 8780016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different regulation of adenylyl cyclase and rolipram-sensitive phosphodiesterase activity on the frontal cortex and hippocampus in learned helplessness rats.
    Itoh T; Abe K; Tokumura M; Horiuchi M; Inoue O; Ibii N
    Brain Res; 2003 Nov; 991(1-2):142-9. PubMed ID: 14575886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: an autoradiographic study.
    Kato H; Araki T; Chen T; Itoyama Y; Kogure K
    Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):403-8. PubMed ID: 9701778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
    Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
    Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.
    Liu S; Laliberté F; Bobechko B; Bartlett A; Lario P; Gorseth E; Van Hamme J; Gresser MJ; Huang Z
    Biochemistry; 2001 Aug; 40(34):10179-86. PubMed ID: 11513595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA; Thompson BE; Pho V
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of noradrenergic lesions on the development of rolipram-sensitive, low-K(m), cyclic AMP specific phosphodiesterase in rat brain.
    Zhang K; Farooqui SM; Jackson KT; O'Donnell JM
    Brain Res Dev Brain Res; 1999 Sep; 116(2):181-9. PubMed ID: 10521562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures.
    Ye Y; Jackson K; Houslay MD; Chandler LJ; O'Donnell JM
    Brain Res Dev Brain Res; 2001 Sep; 130(1):115-21. PubMed ID: 11557100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 May; 305(2):565-72. PubMed ID: 12704225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.
    Fujita M; Imaizumi M; D'Sa C; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Gee AD; Seidel J; Green MV; Pike VW; Duman RS; Innis RB
    Synapse; 2007 Feb; 61(2):78-86. PubMed ID: 17117418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.